Nektar Therapeutics (NKTR) Stock Forecast & Price Target

NKTR$37.27+0.02 +0.05%
Biotechnology
Compare
Market cap$1.07BEnterprise value$1.11BRevenue (TTM)$52.19MMarket position—

Score

45
Neutral
Value
59
Quality
27
Growth
50

Nektar Therapeutics price target

NKTR
Low$50.00
Average$107.20
High$153.00
Upside vs current price+187.6%

The average target of $107.20 is +187.6% versus the current NKTR price of $37.27.

Nektar Therapeutics analyst ratings

RatingAnalysts
Strong buy1
Buy10
Hold4
Sell0
Strong sell0
ConsensusBuy

15 analysts cover NKTR.

Nektar Therapeutics EPS and revenue estimates

The estimate table for the Nektar Therapeutics keeps 2026 EPS $-8.08, 2027 EPS $-10.50, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$-8.08$41.82M
2027$-10.50$53.42M

Is Nektar Therapeutics a buy or sell?

Of the 15 analysts covering Nektar Therapeutics, 11 rate it a buy (1 strong buy and 10 buy), 4 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The NKTR consensus label is Buy, beside 11 buy-side ratings and 0 sell-side ratings.

The average target of $107.20 implies +187.6% versus the current price of $37.27.

the Nektar Therapeutics closes with 11 buy-side ratings and 0 on the sell side. The headcount is Buy.

Reading the Nektar Therapeutics forecast

Analysts are far apart on NKTR. The published low is $50.00, the average is $107.20, and the high is $153.00.

From today's $37.27 print, the NKTR average target is +187.6% away.

Most of the NKTR coverage agrees: 11 of 15 analysts are on the buy side, 4 are at hold, and 0 are on the sell side, and the published consensus is Buy.

Earnings estimates for NKTR are falling: 2026 $-8.08, then 2027 $-10.50.

Coverage of NKTR is broad at 15 analysts, and the average is a crowd rather than a single desk.

Nektar Therapeutics forecast questions

What is the NKTR price target?

The published range for NKTR is $50.00 to $153.00, with an average of $107.20. That average is +187.6% versus the current price of $37.27.

Is Nektar Therapeutics a buy or sell?

Of the 15 analysts covering Nektar Therapeutics, 11 rate it a buy, 4 rate it a hold, and 0 rate it a sell. The consensus is Buy, which for NKTR is 11 on the buy side, 4 at hold, and 0 on the sell side.

What is the EPS estimate for Nektar Therapeutics?

Analyst EPS estimates for Nektar Therapeutics: 2026 $-8.08, 2027 $-10.50.

What is the revenue estimate for Nektar Therapeutics?

Analyst revenue estimates for Nektar Therapeutics: 2026 $41.82M, 2027 $53.42M.

How many analysts cover NKTR?

15 analysts cover NKTR. Their consensus on NKTR is Buy, across those 15.

NKTR price $37.27 +0.02 +0.05%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener